Duration of migraine is a predictor for response to botulinum toxin type A.

Eross EJ, Gladstone JP, Lewis S, Rogers R, Dodick DW. Duration of migraine is a predictor for response to botulinum toxin type A. Headache. 2005 Apr; 45(4):308-14.

View in: PubMed